AXIM BIOTECHNOLOGIES, INC.: 10-Q filed 2019-11-14
What AXIM BIOTECHNOLOGIES, INC. reported in its quarterly report filed 2019-11-14 (fiscal Q3 2019): 37 published measures, 107 facts as tagged in accession 0001078782-19-000861.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-11-14
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001078782-19-000861 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AXIM BIOTECHNOLOGIES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 2,376,645 | USD | |
| At 2018-12-31 | 2,089,254 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 8,554,286 | USD | |
| At 2018-12-31 | 8,171,073 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 1,167,417 | USD | |
| At 2018-12-31 | 1,805,627 | USD | |
| At 2018-09-30 | 632,225 | USD | |
| At 2017-12-31 | 2,057,843 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -863,618 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -5,011,446 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -1,333,696 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -5,775,754 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 403,012 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 513,161 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 6,224 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 28,646 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 2,814,208 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 2,377,623 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 177,493 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 0 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -34,003,930 | USD | |
| At 2018-12-31 | -28,992,485 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 0 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 0 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 0 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 0 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 3,076 | USD | |
| At 2018-12-31 | 5,593 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 1,615,000 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 1,003,840 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -1,114,569 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -5,252,156 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -935,826 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -4,313,025 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 2,322,411 | USD | |
| At 2018-12-31 | 2,022,529 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 55,959 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 167,275 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 89,885 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 349,270 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 3,565,178 | USD | |
| At 2018-12-31 | 3,323,866 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 50,534 | USD | |
| At 2018-12-31 | 53,692 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 38,747 | USD | |
| At 2018-12-31 | 0 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 1,191,305 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 5,347,019 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 938,875 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 4,334,507 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 465,626 | USD | |
| At 2018-12-31 | 9,797 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 76,736 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 94,863 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 3,049 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 21,482 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 326,276 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 418,298 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 3,175 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 7,164 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 426,665 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 1,950,981 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 350,588 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 1,701,986 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 62,785,419 | shares | |
| At 2018-12-31 | 59,582,890 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 27,812,413 | USD | |
| At 2018-12-31 | 22,863,608 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -6,177,638 | USD | |
| At 2019-06-30 | -6,160,833 | USD | |
| At 2019-03-31 | -5,286,684 | USD | |
| At 2018-12-31 | -6,081,819 | USD | |
| At 2018-09-30 | -6,202,685 | USD | |
| At 2018-06-30 | -6,967,417 | USD | |
| At 2018-03-31 | -7,817,203 | USD | |
| At 2017-12-31 | -6,284,493 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 13,704 | USD | |
| At 2018-12-31 | 11,187 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 50,534 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -863,618 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -5,011,446 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -1,333,696 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -5,775,754 | USD | 273 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -5,011,446 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -5,775,754 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 0 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 0 | USD | 273 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -863,618 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -5,011,446 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -1,333,696 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -5,775,754 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 763,801 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 3,393,521 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 587,448 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 2,630,004 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 2,517 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 2,517 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 3,158 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 9,475 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 250,951 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 240,710 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -397,870 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -1,462,729 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 38,747 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 0 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 455,829 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -5,373 | USD | 273 |
Inspect the source
- Entity
- AXIM BIOTECHNOLOGIES, INC. / CIK 0001514946
- Captured
- 2026-09-20T09:13:30.666Z
- SEC response SHA-256
5755093e2dfb1c20119737eacb251a5ef040e09cdc537c89d6edf9272249749e
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001514946.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))